Recombinant Rituximab antibody
-
- Target See all Rituximab products
- Rituximab
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Rituximab antibody is un-conjugated
-
Application
- ELISA, Lateral Flow (LF)
- Purpose
- Anti-Rituximab Antibody (MALS verified)
- Characteristics
- Anti-idiotypic Antibodies
- Grade
- MALS verified
- Immunogen
- Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).
-
-
- Application Notes
- This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
-
- Target
- Rituximab
- Abstract
- Rituximab Products
- Target Type
- Antibody
- Background
- Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.
-